The Emergency Department as an Opportunity for Naloxone Distribution.
Date
2018-11
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Introduction:Substance use disorders, including opioid use disorders, are a major public health concern in the United States. Between 2005 and 2014, the rate of opioid-related emergency department (ED) visits nearly doubled, from 89.1 per 100,000 persons in 2005 to 177.7 per 100,000 persons in 2014. Thus, the ED presents a distinctive opportunity for harm-reduction strategies such as distribution of naloxone to patients who are at risk for an opioid overdose. Methods:We conducted a systematic review of all existing literature related to naloxone distribution from the ED. We included only those articles published in peer-reviewed journals that described results relating to naloxone distribution from the ED. Results:Of the 2,286 articles we identified from the search, five met the inclusion criteria and had direct relevance to naloxone distribution from the ED setting. Across the studies, we found variation in the methods of implementation and evaluation of take-home naloxone programs in the ED. In the three studies that attempted patient follow-up, success was low, limiting the evidence for the programs' effectiveness. Overall, in the included studies there is evidence that distributing take-home naloxone from the ED has the potential for harm reduction; however, the uptake of the practice remained low. Barriers to implementation included time allocated for training hospital staff and the burden on workflow. Conclusion:This systematic review of the best evidence available supports the ED as a potential setting for naloxone distribution for overdose reversal in the community. The variability of the implementation methods across the studies highlights the need for future research to determine the most effective practices.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Gunn, Alexander H, Zachary PW Smothers, Nicole Schramm-Sapyta, Caroline E Freiermuth, Mark MacEachern and Andrew J Muzyk (2018). The Emergency Department as an Opportunity for Naloxone Distribution. The western journal of emergency medicine, 19(6). pp. 1036–1042. 10.5811/westjem.2018.8.38829 Retrieved from https://hdl.handle.net/10161/17825.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Alex Gunn
Nicole Lewellyn Schramm-Sapyta
Dr. Schramm-Sapyta earned her bachelor’s degree in Biochemistry from N.C. State University in 1994 and her doctoral degree in Pharmacology from Vanderbilt University in 2000. She is currently an associate professor of the practice and Associate Director of the Duke Institute for Brain Sciences. She has a long-standing interest in the neurobiology of drug addiction, using rodent models to investigate adolescent vulnerability to addiction. Her scientific expertise in this area supports her passion to bring scientific and clinical knowledge to inform public policy and educate the public about mental health and addiction. Her course offerings at Duke include “Drugs and the Law,” “Reward and Addiction,” and “Biological Bases of Behavior.” She co-leads a Bass Connections team on the subject of “Mental Health and the Justice System in Durham County.”
Her early career was dedicated to exploring the biological basis of drug addiction using rodent behavioral models, with a particular interest in adolescent vulnerability to addiction. This work led her to appreciate the importance of resilience and mental health in individuals and society as a whole, and the role the public policy can play in this area.
Andrew Muzyk
Dr. Andrew Muzyk is an Associate Professor of the Practice of Medical Education at Duke University School of Medicine and an Associate Professor in the Department of Pharmacy Practice at Campbell University College of Pharmacy and Health Sciences. He also holds a Clinical Associate appointment in the Duke University School of Nursing. His professional responsibilities span teaching across multiple health professions programs, serving as a clinical pharmacist on the Medicine–Psychiatry service at Duke University Hospital, and advancing scholarship in health professions education and clinical outcomes research.
Teaching
At Duke University School of Medicine, Dr. Muzyk directs pharmacology content and serves as course director for the Foundations of Patient Care II course, which integrates pharmacology, pathology, microbiology, immunology, and clinical medicine, in the first-year medical school curriculum. He lectures extensively in the first-year medical student curriculum, focusing on central nervous system pharmacology, and previously directed the Biological Psychiatry course for Duke psychiatry residents.
At Campbell University, he teaches pharmacotherapy with an emphasis on psychiatric and substance use disorders, men’s health, and neurology–psychiatry. He co-coordinates the Pharmacoepidemiology and Health Informatics modules and precepts pharmacy students in internal medicine and psychiatry clerkships at Duke University Hospital. Beyond these roles, he contributes to physician assistant, nursing, osteopathic medicine, and other health professions programs at Duke and Campbell, and he mentors graduate students in the University of Michigan’s Master of Health Professions Education program.
Clinical Practice
Dr. Muzyk practices as a clinical pharmacist in the Duke University Hospital Department of Pharmacy. He rounds on the Medicine–Psychiatry inpatient service and provides consultative expertise to the inpatient psychiatry unit and the opioid use disorder consult service.
Scholarship
Dr. Muzyk has authored more than 70 peer-reviewed publications addressing health professions education, psychopharmacology, and hospital-based medication outcomes. His research has appeared in journals such as Academic Medicine, Substance Abuse, Psychosomatics, Academic Psychiatry, American Journal of Pharmaceutical Education, CNS Drugs, and Pharmacotherapy. He has secured over $200,000 in research and educational funding, including support from the National Institute on Drug Abuse, Duke Academy for Health Professions Education and Academic Development, Duke Division of Addiction Medicine, Duke Bass Connections, the Josiah Charles Trent Memorial Foundation, and Campbell University. He is a frequent national speaker on psychiatric and substance use disorders and interprofessional education and regularly lectures for the North Carolina Area Health Education Centers.
Awards
Dr. Muzyk’s contributions have been recognized with numerous honors, including the Dean’s Award for Excellence in Teaching and Educator of the Year from Campbell University, the Association of American Medical Colleges Curricular Innovation Award, the Association for Multidisciplinary Education and Research in Substance Use and Addiction New Educator/Investigator Award, the Duke University Hospital Educator and Researcher of the Year Award, the Duke AHEAD Interprofessional Excellence Award, the Association of Academic Psychiatry Psychiatric Education Award, and the North Carolina Association of Pharmacists Distinguished Young Pharmacist Award.
Education and Training
Dr. Muzyk earned his PharmD from Mercer University College of Pharmacy and completed two years of residency training, culminating in a psychiatric pharmacy residency at UNC Medical Center. He received his Master of Health Professions Education from the University of Michigan and completed the Climate Health Organizing Fellowship through Harvard Medical School and Cambridge Health Alliance.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.
